Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women
Year: 2017
Type: review
Abstract: To identify genetic variants associated with breast cancer prognosis we conduct a meta-analysis of overall survival (OS) and disease-free survival (DFS) in 6042 patients from four cohorts. In young women, breast cancer is characterized by a higher incidence of adverse pathological features, unique gene expression profiles and worse survival, which may relate to germline variation. To explore this hypothesis, we also perform survival analysis in 2315 patients aged ≤ 40 years at diagnosis. Here, we identify two SNPs associated with early-onset DFS, rs715212 (Pmeta = 3.54 × 10−5) and rs10963755 (Pmeta = 3.91 × 10−4) in ADAMTSL1. The effect of these SNPs is independent of classical prognostic factors and there is no heterogeneity between cohorts. Most importantly, the association with rs715212 is noteworthy (FPRP <0.2) and approaches genome-wide significance in multivariable analysis (Pmultivariable = 5.37 × 10−8). Expression quantitative trait analysis provides tentative evidence that rs715212 may influence AREG expression (PeQTL = 0.035), although further functional studies are needed to confirm this association and determine a mechanism.
Source: Nature Communications
Institutions: Southampton General Hospital, University of Southampton, University of Helsinki, Helsinki University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Mayo Clinic, The University of Melbourne, National University of Singapore, Genome Institute of Singapore, University Hospital Southampton NHS Foundation Trust, Universität Ulm
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
Funders: Breast Cancer Research Foundation, Helsingin ja Uudenmaan Sairaanhoitopiiri, University of Southampton, National Breast Cancer Foundation, Cancer Australia, Agency for Science, Technology and Research, Academy of Finland, Syöpäjärjestöt, Medical Research Council, National Health and Medical Research Council, Cancer Council Victoria, Cancer Council NSW, National Cancer Institute
OpenAlex ID: W2769201183
